Last updated on July 2019

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Brief description of study

A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma.

Clinical Study Identifier: NCT02559778

Find a site near you

Start Over

Children's Hospital and Clinics on Minnesota

Minneapolis, MN United States
  Connect »